Why attend?

This event builds bridges amongst the orphan drug community in Asia between pharma companies, patients and regulators. It is essential to attend this event if you want to learn and be a part of future developments of the orphan drug industry in Asia.

Attend to:

  • Engage with fellow orphan drug manufacturers
  • Identify, access and better relate to rare disease patients
  • Evaluate new technologies and drug development strategies
  • Learn how to manage orphan drug research & development risks and costs
  • Form new strategic partnerships to advance orphan drug research & development

Learn about:

  • Current trends of rare diseases in Asia
  • Global & regional initiatives
  • Research & development
  • Clinical trials for orphan drugs
  • Manufacturing of orphan drugs
  • New drug launching & reimbursement
  • Global & regional patient access to orphan drugs